GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (ASX:RLT) » Definitions » Total Liabilities

Renergen (ASX:RLT) Total Liabilities : A$100.22 Mil (As of Aug. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Renergen Total Liabilities?

Renergen's Total Liabilities for the quarter that ended in Aug. 2024 was A$100.22 Mil.

Renergen's quarterly Total Liabilities increased from Aug. 2023 (A$111.03 Mil) to Feb. 2024 (A$111.89 Mil) but then declined from Feb. 2024 (A$111.89 Mil) to Aug. 2024 (A$100.22 Mil).

Renergen's annual Total Liabilities increased from Feb. 2022 (A$80.53 Mil) to Feb. 2023 (A$85.95 Mil) and increased from Feb. 2023 (A$85.95 Mil) to Feb. 2024 (A$111.89 Mil).


Renergen Total Liabilities Historical Data

The historical data trend for Renergen's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen Total Liabilities Chart

Renergen Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Total Liabilities
Get a 7-Day Free Trial 37.89 50.10 80.53 85.95 111.89

Renergen Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.44 85.95 111.03 111.89 100.22

Renergen Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Renergen's Total Liabilities for the fiscal year that ended in Feb. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=46.075+(61.288+4.53
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=111.89

Total Liabilities=Total Assets (A: Feb. 2024 )-Total Equity (A: Feb. 2024 )
=218.391-106.498
=111.89

Renergen's Total Liabilities for the quarter that ended in Aug. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=39.112+(56.375+4.73
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=100.22

Total Liabilities=Total Assets (Q: Aug. 2024 )-Total Equity (Q: Aug. 2024 )
=204.491-104.273
=100.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renergen Total Liabilities Related Terms

Thank you for viewing the detailed overview of Renergen's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Renergen Business Description

Traded in Other Exchanges
Address
25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196
Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Renergen Headlines

No Headlines